He co-founded OriCiro Genomics in December 2018. Prior to founding OriCiro, he was the COO of AnGes, a gene therapy company based in Tokyo, where he worked for sixteen years with increasing responsibilities in business and corporate development. Previously, he was a journalist with NIKKEI, a leading economic newspaper in Japan, covering biotechnology, medicine and science policy. He received a MSc in physics from Tohoku University, Japan, and a MSc in science and technology policy from the University of Sussex, UK.
Brought to you by
